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being siRNAs, but still has its own limitations like silencing off
targets and no access to nuclear genes. Hence among alterna-
tives, catalytic nucleic acids are the best candidates to bet upon.
The aim of this study is to use the catalytic nucleic acids like
Ribozymes and DNAzymes as a candidate to have a control on the
replication of inﬂuenza virus in the host cells.
Methods: The M1 gene of A/PR/8/34 (H1N1)) strains were cloned
in pcDNA 3. The computer based secondary structures of RNA
were analyzed to design the DNAzymes with 10-23 catalytic
motifs and the hammerhead Ribozymes. The DNAzymes and
Ribozymes were also used in combination.
Results: The DNAzymes were able to cleave the M1 RNA at 137
nt position whereas Ribozymes targeted at163 nt position in the
same target. These catalytic nucleic acids were highly efﬁcient
under the simulated physiological conditions. When DNAzymes
and Ribozymes were used in combination the cleavage was en-
hanced as compared to when they were used alone. Further
an siRNA-Ribozyme construct was also designed. We have also
demonstrated the modulation of the expression of target gene in
controlled manner at RNA level by RT-PCR and FACs.
Conclusion: This combinatorial strategy can be used to de-
sign multi target DNA-enzymes and Ribozymes to delay the
appearance of escape mutants because of the low probability of
simultaneous mutations in both the target RNA sites.
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OL-048 P-glycoprotein regulation in Hep3B cells by
polyprenol could decrease the risk of
hepatocarcinogenesis in HBV
Sergejs Kuznecovs*, Ivans Kuznecovs. Cancer Research
Laboratory
Background: Over-expression of P-glycoprotein (Pgp) is associ-
ated with liver cancer development from HBV. The resent results
are also in favour of the idea that glycoprotein synthesis in ma-
lignant tissues is limited by Dolichyl Phosphate (DolP). The aim of
the present study was to investigate the effect of polyprenol (PP)
which provides a DolP substitute in regulation of N-glycosylation
on Pgp over-expression in the development of liver cancer in HBV
infection.
Methods: Human hepatocytes, infected with HBV and human
hepatocarcinoma HEP 3B cell line were used. Pgp was assessed
by an immunohistochemical technique. DolP fractions were anal-
ysed by HPLC methods.
Result: It is conﬁrmed that plasmatic membrans of hepatocytes-
cells contain 7,9–9,4% of Pgp (the total protein amount) as a
resistance marker. HBV infected cells differ from normal hepato-
cytes in Pgp content by 4-5 times and Hep3B cells differ by 10-12
times The study showed 5-fold DolP decrease in HBV infected
cells and 10-fold DolP decrease in Hep3B cells. The investigations
demonstrate that the situation can be changed by treatment with
DolP and PP. The DolP concentration in HBV infected hepatocytes
was returned to the normal level. It is established that DolP in
the concentration 10-6M aid 6-8-fold reducing Pgp in membranes
of HBV infected cells.
Conclusion: These results indicate that noncontrollable accu-
mulation of Pgp in HBV infected cells can be overcomed using
stimulation with DolP substitution. Polyprenol usage can open up
possibilities in liver cancer prevention in HBV infection.
OL-049 T cell immunoglobulin- and
mucin-domain-containing molecule-3 (Tim-3)
mediates natural killer cell suppression in
chronic hepatitis B
Ying Ju*,1, Nan Hou1, Jing Meng1, Xiaoyan Wang1,
Xiaoning Zhang1, Xiaoyan Wang2, Jinjin Wang1, Fang Luan1,
Wei Shi 1, Faliang Zhu1, Chun Guo1, Lining Zhang1,
Wensheng Sun1, Xiaohong Liang1, Lifen Gao1, Chunhong Ma1,3.
1Institute of Immunology; 2Infectious Disease Hospital; 3The Key
Laboratory for Experimental Teratology of the Ministry of
Education
Background/Aims: T cell immunoglobulin- and mucin-domain-
containing molecule-3 (Tim-3) has been shown to inﬂuence
autoimmune diseases, including diabetes and multiple sclerosis,
but its role in viral infection has not been well-deﬁned. In this
study, we investigated the expression and regulatory function of
Tim-3 on natural killer (NK) cells in chronic Hepatitis B (CHB).
Methods: Seventy-six CHB patients, 38 healthy controls, and
18 patients with fatty liver disease (FLD) were studied. Tim-3
expression was detected in both peripheral blood mononuclear
cells (PBMCs) and liver inﬁltrating lymphocytes (LILs) by real-
time RT-PCR, ﬂow cytometric analysis and immunohistochemical
analysis. The roles of Tim-3 in NK cell were detected by ﬂow
cytometric analysis and cytotoxicity assay.
Results: We found the increased Tim-3 expression in PBMCs, LILs
and circulating NK cells from CHB. Increased Tim-3 expression
was also detected on cultured NK92 cells transfected with HBV
expression vector (pCDNA-1.1HBV) and hepatic NK cells from
HBV transgenic mice. Importantly, upon blocking Tim-3 with
a speciﬁc antibody, NK92 cells showed increased cytotoxicity
against HepG2 and HepG2.2.15 cells, accompanied with elevated
interferon gamma (IFN-γ) production. Similarly, enhanced cyto-
toxicity was also observed in PBMCs from CHB patients treated
with anti-Tim-3.
Conclusion: HBV infection upregulates Tim-3 expression on NK
cells, which may in turn suppress NK cell function during CHB.
OL-050 The study on the characters of HBV-speciﬁc T
cells and liver damage between HBeAg(+) and
HBeAg(–) CHB patients
Guoping Peng*,1, Wei Wu1, Xufei Tan1, Shuping Li 1,
Yiqiong Chen2, Zhi Chen1. 1National Key Laboratory of
Infectious Diseases, Institute of Infectious Diseases, First
Afﬁliated Hospital, Medical college, Zhejiang University;
2Institute of Immunology, Zhejiang University
Objectives: To study the quantity and quality of HBV-speciﬁc T
cells in chronic hepatitis B (CHB) patients with different HBeAg
status, and to investigate the extent of liver damage.
Methods: The serum HBV markers, liver damage, the frequency
and Foxp3 expression of CD4+CD25+ regulatory T cells (Treg),
and the expression levels of PD-1, CTLA-4 on HBV-speciﬁc T cells
were measured. HBV antigens speciﬁc T-cell responses, with or
without anti-PD-1 mAb and/or anti-CTLA-4 mAb blocking, were
also tested.
Results: The demographic characters, serum ALT levels, the fre-
quency and Foxp3 expression of Treg were similar between two
groups, and the serum HBV DNA levels were higher in HBeAg(+)
patients. The liver necroinﬂammation was comparatively severe
in HBeAg(–) patients (P=0.052), while the median percentage of
liver cirrhosis was much higher in HBeAg(+) patients. The differ-
ence of HBV-speciﬁc T-cell frequency was not signiﬁcant, whereas
the expression levels of PD-1 and CTLA-4 on HBV-pentamer(+)
T cells were higher in HBeAg(+) patients. Combined using of
anti-PD-L1 and anti-CTLA-4 mAb could signiﬁcantly increase the
cellular proliferation in both groups, and markedly enhanced the
IFN-γ production in HBeAg(+) patients.
Conclusion: The persistency of HBeAg could induce higher ex-
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pression of PD-1 and CTLA-4 on the HBV-speciﬁc T cells, which
may associate with the low ability of HBV-speciﬁc T-cell re-
sponses, high serum HBV DNA levels and high percentage of liver
cirrhosis in HBeAg(+) patients.
OL-051 Regulatory polymorphisms in the IL-10 gene
promoter and HBV-related acute liver failure in
the Chinese population
Zehui Yan*, Guohong Deng, Wenting Tan, Xiaohong Wang,
Qing Mao, Yuming Wang. Department of Infectious Diseases,
Southwest Hospital, The Third Military Medical University,
Chongqing, PR China
Background: Recent reports indicated that high levels of IL-
10 contribute to the monocytes paralysation and poor clinical
outcome in acute liver failure (ALF).
The aim of this study was to determine the possible associa-
tion of the polymorphisms in the IL-10 gene promoter with the
susceptibility to HBV-related ALF.
Methods: The IL-10 gene promoter polymorphisms were geno-
typed in 414 unrelated healthy blood donors, 367 asymptomatic
HBV carriers and 345 HBV-related ALF patients using the poly-
merase chain reaction-restriction fragment length polymorphism
assay or ampliﬁcation refractory mutation system-polymerase
chain reaction. Functional analyses were conducted to verify the
biological signiﬁcances of the associated genetic variations.
Results: The allele frequencies of IL-10 -592C and -819C were sig-
niﬁcantly higher in HBV-related ALF patients than in blood donors
and asymptomatic HBV carriers. Logistic regression analysis and
stratiﬁcation analysis with adjustment for age and sex indicated
that the polymorphisms of A-592C and T-819C were associated
with susceptibility to HBV-related ALF (P = 6.9×10−7), and the
-1082A-819C-592C haplotype in the IL-10 gene promoter were
associated with an increased susceptibility to ALF in HBV carriers
(dominant model, P = 0.0002, OR = 1.60, 95%CI 1.25-2.07). Func-
tional analyses showed that the A-592C polymorphism is a nuclear
proteins binding site, and the disease susceptible -592C allele
had a higher transcription activity compared with -592A allele.
Conclusions: Our study emphasizes the importance of IL-10 in
the pathophysiology of HBV-related ALF on the population level.
OL-052 A mathematical model with time-delay immune
response for adefovir treatment
Shaopeng Chen, Yongmei Su, Lequan Min*. Applied Science
School, University of Science and Technology, Beijing
Objectives: The immune response is often initiated with time-
delay and HBV DNA always rebound with shaking after stopping
treatment. Based on K Borroto-Esoda et.al’s adefovir clinical
data and the HBV infection dynamic model proposed by Nowak
et al., we set up a mathematical model with time delay immune
response to simulate the viral dynamics of the clinical data.
Methods: A model of HBV is described by four variables: x, y,
v, z represent uninfected cells, infected cells, free virus, and
immune system effector cells, respectively. The model includes
11 parameters: λ, d, β, a, p, k, k2, u, c, b, τ. The meanings of λ,
d, β, a, k and u are the same as those given in Nowak’s model,
k2 represents the curative effect, and τ represents time-delay.
During treatment, we choose {λ, d, β, a, p, k, k2, u, c, b, τ}
= {4.621×105, 6.9×10-3, 0.0708, 6.9×10-3, 1.5×10-9, 2.9, 2.832,
0.68, 0.35, 0.02251, 10.6}. During off-treatment, we choose k2=0
with other parameters unchanged.
Results: The simulation data of our model are qualitatively
agreement with the clinical ones, especially the HBV DNA re-
bound shaking data during the off-treatment.
Conclusion: The results show that our time-delay immune model
may possibly capture the dynamics of HBV infection and anti-HBV
infection treatment.
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OL-053 Polymorphism of HLA-DRB1 of the Uyghur
population in chronic hepatisis B in Khotan area,
Xinjiang, China
Tuohuti Kurexijiang*,1, Wupuer Halmurat2, Yunusi Kurexi 3,
Zhixing Zhang, Ruxianguli Shawuer. 1Uyghur Traditional
Medicine Hospital of Khotan Area, Xinjiang, PR China, Khotan,
China; 2Xinjiang Medical University, Urumqi, China Xinjiang
Medical University, Urumqi, China; 3HLA Laboratory, Beijing Red
Cross Blood Center, Beijing, China
Objective: To understand the polymorphism of HLA-DRB1 of the
Uyghurs in Khotan Area, Xinjiang, China and the association with
chronic hepatisis B.
Methods: Reverse-polymerase chain reaction sequence speciﬁc
oligonucleotide probes (PCR SSOP) combined with Luminex Flow
Cytometry were used to genotype HLA-DRB1 alleles in 56 unre-
lated healthy Uyghurs controls and 41 chronic hepatisis B Uyghurs
patients of Khotan Area, Xinjiang, China.
Results: 13 DRB1 alleles covered all serology speciﬁcities could
be detected, and their frequencies were calculated in 2 groups.
Conclusion: This study provided the normal allele frequencies
of HLA-DRB1 and linkage disequilibrium with chronic hepatisis
B in Uyghurs in Khotan Area, Xinjiang of China, which may be
of signiﬁcance in the studies on population genetics and disease
association.
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OL-054 Identiﬁcation, distribution, antimicrobial
susceptibility and molecular epidemiology of new
serotype 6C Streptococcus pneumoniae in China
Zunjie Liu*, Kaihu Yao, Lin Yuan, Wei Gao, Sangjie Yu,
Yonghong Yang. Beijing Pediatric Research Institute, Beijing
Children’s Hospital afﬂiated to Capital Medical University
Objectives: To investigate the identiﬁcation methods of the new
serotype 6C; Surveillance the antimicrobial susceptibility and
molecular epidemiology of the new serotype 6C Streptococcus
Pneumonmiae from China.
Methods: The new serotype 6C Streptococcus Pneumonmiae
were determined by multibean assay in USA, Serological method
using the antiserum of 6C in our laboratory and molecular biology
method by multiplex PCR ampliﬁcation of capsular gene targets.
Antimicrobial susceptibility to erythromycin and beta-lactam an-
tibiotic were detected by E-Test. PCR was used to detect genes
ermB and mefA. The typing methods of molecular biology were
used to show the homology of all serotype 6C strains.
Results: 10 serotype 6C isolates were determined from 100
serotype 6A by the three methods, 9 were isolated in Beijing
and 1 in Guangzhou, 6 strains were isolated in Beijing in 1997.
All strains of serotype 6C were resistant to erythromycin but
susceptible to beta-lactam antibiotic. 8 isolates were detected
only ermB and 2 only mefA. All isolates of serotype 6C were
distributed 3 Pbps types, 4 PFGE types and 4 MLST types respec-
tively. Pbps types I, PFGE types I and MLST types I include 6, 7
and 7 strains respectively.
Conclusions:There were three methods can be used to deter-
mine the new serotype 6C Streptococcus Pneumonmiae. The new
serotype 6C could be mainly identiﬁed ten years ago in China
and all strains were susceptible to beta-lactam antibiotic but
resistant to erythromycin.The gene typing present a diversity,
but more isolates were in one type.
